Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

288.24
-3.2600-1.12%
Post-market: 289.341.10+0.38%19:30 EDT
Volume:1.09M
Turnover:312.29M
Market Cap:13.76B
PE:-59.05
High:291.41
Open:285.91
Low:284.34
Close:291.50
52wk High:303.31
52wk Low:144.26
Shares:47.74M
Float Shares:47.20M
Volume Ratio:1.22
T/O Rate:2.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.85
PE(LYR):-98.98

Loading ...

Movement Alert|Charles River Laboratories Rises 7.74% in Regular Trading, CRO Sector Rallies as Multiple Banks Raise Price Targets

Market Focus
·
Jul 28

Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration

GlobeNewswire
·
Jul 28

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 28

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 25

Charles River Laboratories International Inc. Stock Advances 4.8%, Outperforms Peers

Dow Jones
·
Jul 24

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 21

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 18

Press Release: Sobi Q2 2026 Report: Significant Growth with Important Pipeline Progress

Dow Jones
·
Jul 16

Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 16

Charles River Laboratories to Report Q2 2026 Financial Results on August 5th

Deep News
·
Jul 15

Charles River Labs Updates Financial Calendar with Second-quarter Earnings Release and Conference Call

Reuters
·
Jul 15

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 14

Baird Adjusts Charles River Laboratories International Price Target to $255 From $213, Maintains Outperform Rating

MT Newswires Live
·
Jul 13

Charles River Provides Ngs Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches

THOMSON REUTERS
·
Jul 13

Charles River Laboratories International Inc: to Perform Viral Safety Release Testing on Clinical Batches of Ala-101

THOMSON REUTERS
·
Jul 13

Charles River to Provide GMP NGS Testing Services to Arovella Therapeutics Under New Collaboration

Reuters
·
Jul 13

Charles River Laboratories International Inc : Mizuho Raises Target Price to $230 from $192

THOMSON REUTERS
·
Jul 13

Charles River Laboratories International Inc. Stock Rallies 4.3%, Outperforms Peers

Dow Jones
·
Jul 10

U.S. Stocks on the Move-natera, Nlight, Micron

Reuters
·
Jul 10

Charles River Labs is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jul 10